arrow
B

Berenice Silva

hospital italiano de buenos aires
H指数:13
被引数:604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Frequency of MRI abnormalities in adult-onset MOG-IgG-associated disease at disease presentation: A cohort of Latin American patients

成人起病的MOG-IgG相关疾病在疾病初发时的MRI异常频率:一项拉丁美洲患者队列研究

2026-04-270
PRE
Real-world cost of disease-modifying treatments administered by intravenous infusion in relapsing-remitting multiple sclerosis patients from Argentina

阿根廷复发缓解型多发性硬化患者静脉输注给药的疾病修正治疗实际成本

2026-04-010
PRE
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs

多国真实世界中克拉屈滨片剂依从性的见解:来自患者支持项目的结果

2026-03-280
PRE
Access, satisfaction, adherence and safety to subcutaneous natalizumab compared to intravenous natalizumab in multiple sclerosis in a real-life cohort: first report from Latin America

与静脉注射纳他珠单抗相比,在真实世界队列中皮下注射纳他珠单抗在多发性硬化中的可及性、满意度、依从性和安全性:拉丁美洲首报

2025-10-220
OA
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study

克拉屈滨作为50岁以上多发性硬化患者治疗方案的疗效与安全性:一项真实世界研究

2025-10-140
PRE
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments

在高疗效治疗时代,与复发活动无关的进展(PIRA)

2025-09-210
PRE
Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina

使用EDSS-Plus评估中度及重度残疾的复发缓解型多发性硬化症 ambulatory 患者 disability progression 的确定:一项在阿根廷进行的前瞻性研究

2025-07-010
PRE
Eye movement deficits in Multiple Sclerosis: Characterizing executive problems as the disease worsens.

多发性硬化中的眼动缺陷:表征疾病恶化过程中的执行功能问题。

2025-03-010
PRE
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodology

拉丁美洲NMOSD治疗建议:利用基于共识的RAND/UCLA方法

2025-02-010
PRE
Additional Cladribine tablets treatment courses in multiple sclerosis patients. A retrospective observational study in Latin American countries

多发性硬化患者接受额外克拉屈滨片治疗疗程。一项在拉丁美洲国家进行的研究回顾性观察研究。

2025-02-010
PRE
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry

根据患者的年龄和疾病活动选择多发性硬化症的疾病修饰疗法: 来自全国注册中心的数据

2024-06-011
PRE
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
2024-01-211
PRE
Consensus recommendations on the management of multiple sclerosis patients in Argentina
2020-02-0112
PREAI
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients (vol 385, pg 217, 2018)
2018-04-015
OAAI
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients
2018-02-0115
PREAI